These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 28698581)

  • 1. GTSE1 promotes cell migration and invasion by regulating EMT in hepatocellular carcinoma and is associated with poor prognosis.
    Wu X; Wang H; Lian Y; Chen L; Gu L; Wang J; Huang Y; Deng M; Gao Z; Huang Y
    Sci Rep; 2017 Jul; 7(1):5129. PubMed ID: 28698581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing GTSE-1 expression inhibits proliferation and invasion of hepatocellular carcinoma cells.
    Guo L; Zhang S; Zhang B; Chen W; Li X; Zhang W; Zhou C; Zhang J; Ren N; Ye Q
    Cell Biol Toxicol; 2016 Aug; 32(4):263-74. PubMed ID: 27240802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GTSE1 promotes SNAIL1 degradation by facilitating its nuclear export in hepatocellular carcin oma cells.
    Li SS; Chen DM; Chen LB; Wei H; Wang JL; Xiao J; Huang YH; Lian YF
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
    Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
    Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GTSE1, CDC20, PCNA, and MCM6 Synergistically Affect Regulations in Cell Cycle and Indicate Poor Prognosis in Liver Cancer.
    Zheng Y; Shi Y; Yu S; Han Y; Kang K; Xu H; Gu H; Sang X; Chen Y; Wang J
    Anal Cell Pathol (Amst); 2019; 2019():1038069. PubMed ID: 32082966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High G2 and S-phase expressed 1 expression promotes acral melanoma progression and correlates with poor clinical prognosis.
    Xu T; Ma M; Chi Z; Si L; Sheng X; Cui C; Dai J; Yu S; Yan J; Yu H; Wu X; Tang H; Yu J; Kong Y; Guo J
    Cancer Sci; 2018 Jun; 109(6):1787-1798. PubMed ID: 29660787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Noncoding RNA AK021443 Promotes Cell Proliferation and Migration by Regulating Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells.
    Yang J; Li J; Liu B; Zhang R; Gu F; Zhao J; Cheng S
    DNA Cell Biol; 2018 May; 37(5):481-490. PubMed ID: 29638164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway.
    Jin Y; Wang J; Han J; Luo D; Sun Z
    Exp Cell Res; 2017 Nov; 360(2):210-217. PubMed ID: 28890291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.
    Zhao Q; Zheng B; Meng S; Xu Y; Guo J; Chen LJ; Xiao J; Zhang W; Tan ZR; Tang J; Chen L; Chen Y
    Biomed Pharmacother; 2019 Jun; 114():108864. PubMed ID: 30981107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCR7 preservation via histone deacetylase inhibition promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells.
    Yang L; Chang Y; Cao P
    Exp Cell Res; 2018 Oct; 371(1):231-237. PubMed ID: 30107147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAK1 promotes proliferation, migration and invasion of hepatocellular carcinoma by facilitating EMT via directly up-regulating Snail.
    Cao F; Yin LX
    Genomics; 2020 Jan; 112(1):694-702. PubMed ID: 31071459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DEPTOR induces a partial epithelial-to-mesenchymal transition and metastasis via autocrine TGFβ1 signaling and is associated with poor prognosis in hepatocellular carcinoma.
    Chen J; Zhu H; Liu Q; Ning D; Zhang Z; Zhang L; Mo J; Du P; Liu X; Song S; Fan Y; Liang H; Liu J; Zhang B; Chen X
    J Exp Clin Cancer Res; 2019 Jun; 38(1):273. PubMed ID: 31228948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CAPZA1 modulates EMT by regulating actin cytoskeleton remodelling in hepatocellular carcinoma.
    Huang D; Cao L; Zheng S
    J Exp Clin Cancer Res; 2017 Jan; 36(1):13. PubMed ID: 28093067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type IIA topoisomerase (TOP2A) triggers epithelial-mesenchymal transition and facilitates HCC progression by regulating Snail expression.
    Dong Y; Sun X; Zhang K; He X; Zhang Q; Song H; Xu M; Lu H; Ren R
    Bioengineered; 2021 Dec; 12(2):12967-12979. PubMed ID: 34939898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anti-tumor activities of Neferine on cell invasion and oxaliplatin sensitivity regulated by EMT via Snail signaling in hepatocellular carcinoma.
    Deng G; Zeng S; Ma J; Zhang Y; Qu Y; Han Y; Yin L; Cai C; Guo C; Shen H
    Sci Rep; 2017 Jan; 7():41616. PubMed ID: 28134289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kindlin-2 promotes hepatocellular carcinoma invasion and metastasis by increasing Wnt/β-catenin signaling.
    Lin J; Lin W; Ye Y; Wang L; Chen X; Zang S; Huang A
    J Exp Clin Cancer Res; 2017 Sep; 36(1):134. PubMed ID: 28969700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q
    Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.